The U.S. is the land of opportunity, and not surprisingly, many of the most successful companies in the world have started right here. Today, I wanted to look at three up-and-coming U.S. companies ...

President Donald Trump is right that Americans pay too much for many pharmaceuticals. However, his legally unenforceable ...

What a pity that a Republican administration needs to be reminded that this misguided policy won’t make America healthy or ...

The Bay Area's biotech industry faces an uncertain future after 50 years. But industry leaders see a history of resilience ...

The discovery of recombinant DNA proved that biology, not chemistry alone, could create new medicines like life-saving insulin.

Tough economic conditions in the biotech industry have led some companies to stake ground on cheaper shores in Alameda ...

Biowave will address this lackluster entrepreneurial activity and bring more VC investment into India’s life sciences.

The UNC technology, developed by Pediatrics Professor Chengwen Li, M.D., Ph.D., uses adeno-associated viruses (AAVs) to ferry ...

The company has increased manufacturing capacity from pilot scale to 1 million liters annually, and can now assist customers ...

McKesson Corporation announced its intention to separate its Medical-Surgical Solutions segment into an independent company.

Michael Yee, Senior Biotech Analyst at Jefferies, appeared on CNBC to discuss how tariffs and policy risks are pressuring the ...